Screener
AbCellera Biologics Inc. ABCL Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
| Line item | Three months ended June 30, 2025 | Three months ended June 30, 2026 | Six months ended June 30, 2025 | Six months ended June 30, 2026 |
|---|---|---|---|---|
| Revenue: | ||||
| Research fees | $6,639 | $3,901 | $10,707 | $12,021 |
| Licensing and royalty revenue | 10,445 | 149 | 10,613 | 341 |
| Total revenue | 17,084 | 4,050 | 21,320 | 12,362 |
| Operating expenses: | ||||
| Research and development(1) | 39,213 | 45,987 | 81,711 | 92,649 |
| Sales, general, and administrative(1) | 21,986 | 13,850 | 41,054 | 26,185 |
| Depreciation and amortization | 5,470 | 6,990 | 10,801 | 13,828 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is AbCellera Biologics Inc.'s total revenue?
- AbCellera Biologics Inc. (ABCL) reported total revenue of $4.05M in Q2 2026.
- How has AbCellera Biologics Inc.'s total revenue changed year-over-year?
- AbCellera Biologics Inc.'s total revenue decreased by 76.3% year-over-year, from $17.08M to $4.05M.
- What is the long-term trend for AbCellera Biologics Inc.'s total revenue?
- Over 4 years (2021 to 2025), AbCellera Biologics Inc.'s total revenue has grown at a -33.1% compound annual growth rate (CAGR), from $375.22M to $75.13M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about AbCellera Biologics Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude